// App-Quantinova.ai

5600 : Feasibility of circulating tumour cell (CTC) enumeration and molecular profiling (MP) as a biomarker in advanced endometrial cancer (aEC).

Researchers

Presenter

  • Charlotte Rose Lemech

Principal Investigators

  • Leah Ensell

  • Jennifer Paterson

  • Tim Mould

  • Tim Meyer

  • John Anthony Hartley

  • Anita Mitra

  • Jonathan A. Ledermann

  • Mary McCormack

  • Natalie Griffin

  • Rupali Arora

  • Hendrik-Tobias Arkenau

  • Martin Widschwendter

  • Nicola MacDonald

  • Adeola Olaitan

  • Rebecca Sophie Kristeleit

  • Gemma Eminowicz

  • Helen Lowe

Medical Centers

  • University College London Advanced Diagnostics, London, United Kingdom

  • Universiy College London Hospital, London, United KingdomUniversity College London Cancer Institute, London, United KingdomUniversity College London Hospital, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Sarah Cannon Research Institute, London, United Kingdom

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • University College London Cancer Institute, University College London Cancer Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Endometrial Cancer

Biomarkers

  • Circulating tumor cells

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved